Gabriel González-Escamilla

Jan 14, 2025 | nature.com | María Díez-Cirarda |Lidia Gil-Martínez |Gabriel González-Escamilla |Miguel Yus-Fuertes

AbstractPatients with post-COVID condition (PCC) present with diverse symptoms which persist at long-term after SARS-CoV-2 infection. Among these symptoms, cognitive impairment is one of the most prevalent and has been related to brain structural and functional changes. The underlying mechanisms of these cognitive and brain alterations remain elusive but neuroinflammation and immune mechanisms have been majorly considered.

Sep 7, 2023 | frontiersin.org | Gabriel González-Escamilla

Currently available pharmacological treatments for many neuropsychiatric diseases still have limitations in terms of efficacy and safety. This necessitates the exploration of new approaches in drug development for central nervous system (CNS) disorders.